Why is 3B Blackbio DX Ltd ?
1
Poor long term growth as Net Sales has grown by an annual rate of -10.27% and Operating profit at -16.77% over the last 5 years
2
Flat results in Sep 25
- PBT LESS OI(Q) At Rs 14.11 cr has Fallen at -11.09%
3
With ROE of 16.5, it has a Very Expensive valuation with a 3.7 Price to Book Value
- The stock is trading at a fair value compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -33.83%, its profits have risen by 13.2% ; the PEG ratio of the company is 1.7
4
Despite the size of the company, domestic mutual funds hold only 0% of the company
- Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
5
Underperformed the market in the last 1 year
- Even though the market (BSE500) has generated returns of 2.06% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -33.83% returns
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Healthcare Services)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is 3B Blackbio for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
3B Blackbio
-33.83%
-0.60
56.44%
Sensex
4.67%
0.40
11.83%
Quality key factors
Factor
Value
Sales Growth (5y)
-10.27%
EBIT Growth (5y)
-16.77%
EBIT to Interest (avg)
40.89
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.24
Sales to Capital Employed (avg)
0.54
Tax Ratio
25.22%
Dividend Payout Ratio
7.19%
Pledged Shares
0
Institutional Holding
4.46%
ROCE (avg)
38.49%
ROE (avg)
18.06%
Valuation Key Factors 
Factor
Value
P/E Ratio
23
Industry P/E
31
Price to Book Value
3.72
EV to EBIT
21.54
EV to EBITDA
20.93
EV to Capital Employed
4.58
EV to Sales
9.97
PEG Ratio
1.71
Dividend Yield
0.31%
ROCE (Latest)
21.27%
ROE (Latest)
16.46%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
No Trend
No Trend
Technical Movement
7What is working for the Company
OPERATING CF(Y)
Highest at Rs 44.47 Cr
CASH AND CASH EQUIVALENTS(HY)
Highest at Rs 72.13 cr
NET SALES(Q)
Highest at Rs 33.90 cr
PAT(Q)
Highest at Rs 14.71 cr.
EPS(Q)
Highest at Rs 17.16
-3What is not working for the Company
PBT LESS OI(Q)
At Rs 14.11 cr has Fallen at -11.09%
Loading Valuation Snapshot...
Here's what is working for 3B Blackbio
Operating Cash Flow - Annually
Highest at Rs 44.47 Cr and Grown
each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (Rs Cr)
Net Sales - Quarterly
Highest at Rs 33.90 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 14.71 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 17.16
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Cash and Cash Equivalents - Half Yearly
Highest at Rs 72.13 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Here's what is not working for 3B Blackbio
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 14.11 cr has Fallen at -11.09%
Year on Year (YoY)MOJO Watch
Near term PBT trend is very negative
PBT less Other Income (Rs Cr)
Non Operating Income - Quarterly
Highest at Rs 5.51 cr
in the last five quartersMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating Income






